Rein Therapeutics Inc. (RNTX)

NCM – Real Time Price. Currency in USD

1.09

-0.02 (-2.23%)

Market open: May 13, 2026, 9:49 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-1K

-63K

-119K

-169K

Gross Profit

-1K

-63K

-119K

-169K

Operating expenses (excl. COGS)

-22M

-28M

-15M

-27M

Operating Income

-22M

-28M

-15M

-28M

Non-operating income, total

-29M

-36M

-384K

318K

Pretax income

-51M

-64M

-16M

-27M

Equity in earnings

Taxes

712K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-50M

-63M

-16M

-27M

Rein Therapeutics Inc. (RNTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Rein Therapeutics Inc. (RNTX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Rein Therapeutics Inc. (RNTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Rein Therapeutics Inc. (RNTX)

Income Statement (Annual)

Income Statement (Annual)